Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repaglinide versus insulin in cystic fibrosis-related diabetes (early diagnosed)
2006-001254-27Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2006
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in cystic fibrosis-related diabetes (CFRD) comparing Repaglinide arm with Insulin arm (2 arms). Primary endpoint: Primary HbA1c after 2 years. Started Aug 2006; status: completed.
02
Drugs
repaglinidehuman insulin
03
Conditions
cystic fibrosis-related diabetes (CFRD)
Beyond the preview
Go deeper on 2006-001254-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001254-27.